Medicus Sciences Acquisition Corp.

Medicus Sciences Acquisition Corp. (Nasdaq: MSAC) is a blank check special purpose acquisition company formed to pursue a business combination in the life sciences and healthcare sector. The company completed its initial public offering in 2021 and filed a Form 10-Q with the Securities and Exchange Commission on August 11, 2022, reflecting its active search for a suitable acquisition target at that time. MSAC operates within the broader healthcare deal space, targeting opportunities across medical sciences and adjacent industries. For full filing history, sponsor details, and real-time deal status on MSAC, sign up for a free account at SpacDesk.